SB5 (BIIB606)
Approved
Approval ID
002d3e04-7558-4e22-85bb-09e30566bd0b
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 6, 2023
Manufacturers
FDA
Catalent Indiana, LLC
DUNS: 172209277
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
adalimumab-bwwd
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code61434-005
Product Classification
G
Generic Name
adalimumab-bwwd
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 21, 2022
FDA Product Classification
INGREDIENTS (1)
ADALIMUMAB-BWWDActive
Quantity: 40 mg in 0.8 mL
Code: FYS6T7F842
Classification: ACTIB